Skip to main content

ENGLISH · EVIDENCE OVERVIEW

Vardenafil
evidence profile

Phosphodiesterase type 5 (PDE5) inhibitor. This is a concise English overview, not a full translation. Read the evidence boundaries and original sources below; the detailed study and risk discussion remains available in Thai.

What do Class, Grade and Risk mean?

Vardenafil: conceptual scientific illustration for Sexual Medicine Pharmacology
VISUAL GUIDE · Vardenafil

Sexual Medicine Pharmacology

Category-level conceptual illustration, not a map of this molecule's receptor targets. It is not a treatment outcome and does not establish efficacy or safety.

QUICK ANSWER · AEO / GEO

A PDE5 inhibitor with approved erectile-dysfunction products and a distinct QT-interval safety consideration in addition to class-wide cardiovascular and nitrate boundaries.

01

ENTITY FACTS

What should readers identify first?

MOLECULEVardenafil
PHARMACOLOGYPhosphodiesterase type 5 (PDE5) inhibitor
PRIMECORE CLASSA
EVIDENCE GRADEA
RESEARCH TOPICSexual Medicine Pharmacology
LAST REVIEWED2026-08-29

What remains unknown?

English translation is not yet verified for 3 excerpt(s). This is a language gap, not an absence of risks or uncertainty.

Read original excerpts (Thai / mixed language)
  • การอนุมัติใน EU หรือสหรัฐฯ ไม่ยืนยันการอนุมัติผลิตภัณฑ์เดียวกันในไทย
  • ไม่ควรเหมารวมว่าคำเตือนและ interactions เหมือน PDE5 inhibitor ทุกตัวทุกประการ
  • ชื่อ Levitra บนสินค้าออนไลน์ไม่ยืนยันว่าเป็นผลิตภัณฑ์ที่ได้รับอนุมัติ

What limits these conclusions?

Insufficient data in the current dataset

This overview does not replace the detailed adverse-event and product-specific risk discussion in the complete Thai profile or the original sources.

02

EVIDENCE BOUNDARY

What this overview does not establish

  • An evidence grade does not rank this molecule against another treatment.
  • A molecule name does not establish the identity, purity or regulatory status of a product.
  • Animal, cell or biomarker findings do not automatically establish human clinical benefit.
  • Approval in one country or indication does not transfer globally.

Where can I check the evidence?

Original sources from the same evidence record used by Compare. Read each source's population, methods, limitations and date; a citation is not product endorsement.

  1. DailyMed — vardenafil label
  2. EMA — Levitra EPAR
  3. EAU — Management of erectile dysfunction
03

FAQ · ANSWER ENGINE

Frequently asked questions

What is Vardenafil?

Vardenafil is described pharmacologically as Phosphodiesterase type 5 (PDE5) inhibitor. A PDE5 inhibitor with approved erectile-dysfunction products and a distinct QT-interval safety consideration in addition to class-wide cardiovascular and nitrate boundaries.

Does Vardenafil have strong evidence?

PrimeCoreBio records Evidence Grade A. This grade describes evidence strength, not comparative effectiveness or suitability for an individual.

Is Vardenafil approved everywhere?

No global conclusion should be inferred. PrimeCore Class A must be read with the exact product, country and indication on the source-rich profile.

Medical Disclaimer

Educational information only. This page does not provide diagnosis, treatment, prescribing, dosage, injection instructions or individual medical advice.

Contact PrimeCoreBio

Choose a contact channel

General information only · No sales or medical advice